| Product Name | MF | CAS | Details |
|---|
| 4-(trans-4-Ethylcyclohexyl)cyclohexanone | C14H24O | 150763-46-5 | Details |
| 5-Methyl-2,3-dihydrofuran | C5H8O | 1487-15-6 | Details |
| Bis(4-(tert-butyl)phenyl)methanone | C21H26O | 15796-82-4 | Details |
| (S)-2-Aminohept-6-enoic acid | C7H13NO2 | 166734-64-1 | Details |
| (3'S,3R,4R)-Ezetimibe | C24H21F2NO3 | 1478664-02-6 | Details |
| 2,4-Dichloro-1-(dichloromethyl)benzene | C7H4Cl4 | 134-25-8 | Details |
| 2-Ethylhexanoic acid (manganese salt) | C16H30MnO4 | 15956-58-8 | Details |
| Calcium iodide tetrahydrate | CaH8I2O4 | 13640-62-5 | Details |
| 5-Bromo-2-chloro-4-morpholinopyrimidine | C8H9BrClN3O | 139502-01-5 | Details |
| N,N-Di-m-tolylaniline | C20H19N | 13511-11-0 | Details |
| (R,E)-7-(4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid (Rosuvastatin Impurity) | C22H26FN3O6S | 1422619-13-3 | Details |
| Aureusimine B | C14H16N2O | 170713-71-0 | Details |
| 4-Amino-N-((1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-hydroxybenzamide (Amisulpride Impurity) | C16H25N3O4S | 148516-54-5 | Details |
| 1-(5H-chromeno[2,3-b]pyridin-7-yl)-1,1-dimethoxypropan-2-ol | C17H19NO4 | 143436-36-6 | Details |
| Pyrrolidin-1-amine | C4H10N2 | 16596-41-1 | Details |
| 4-(2-Octylamino)diphenylamine | C20H28N2 | 15233-47-3 | Details |
| 7-Octenyldimethylchlorosilane | C10H21ClSi | 17196-12-2 | Details |
| cis-4-(Benzyloxycarbonylamino)cyclohexylamine | C14H20N2O2 | 149423-70-1 | Details |
| (S)-N-Methylpyrrolidin-3-amine | C5H12N2 | 139015-32-0 | Details |
| Hexyl 3-oxobutanoate | C10H18O3 | 13562-84-0 | Details |
| Phloxine B (free acid) | C20H4Br4Cl4O5 | 13473-26-2 | Details |
| 7-Methyl-DL-tryptophan | C12H14N2O2 | 17332-70-6 | Details |
| Nickel(II) tetrafluoroborate, 40% solution in water | BF4Ni+ | 14708-14-6 | Details |
| L-Galactono-1,4-lactone | C6H10O6 | 1668-08-2 | Details |
| Ethyl 5-fluoro-3-iodo-1H-indole-2-carboxylate | C11H9FINO2 | 167631-21-2 | Details |
| 5-Bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine (Brimonidine Impurity) | C11H8BrN5 | 151110-15-5 | Details |
| 4-Ethyl-4'-iodo-1,1'-biphenyl | C14H13I | 17078-76-1 | Details |
| 5-(2-Hydroxypropan-2-yl)-2-propyl-1H-imidazole-4-carboxylic acid | C10H16N2O3 | 144690-04-0 | Details |
| 5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid | C9H9NO5 | 143382-03-0 | Details |
| 3,6-Dibromo-9-(2-ethylhexyl)-9H-carbazole | C20H23Br2N | 173063-52-0 | Details |
| 1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine | C13H18ClN5O4 | 147539-23-9 | Details |
| 4-Amino-N-(1-ethylpiperidin-3-yl)-5-(ethylsulfonyl)-2-methoxybenzamide (Amisulpride Impurity) | C17H27N3O4S | 148516-68-1 | Details |
| Loperamide phenyl | C35H37ClN2O2 | 1391052-94-0 | Details |
| 1,2-Bis(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethane (Quetiapine Impurity) | C40H44N6O2S2 | 1371638-05-9 | Details |
| 4-(Pyrrolidin-3-yl)pyridine | C9H12N2 | 150281-47-3 | Details |
| 1-Cyclopropylpiperazine dihydrochloride | C7H16Cl2N2 | 139256-79-4 | Details |
| (S)-5-(Aminomethyl)pyrrolidin-2-one | C5H10N2O | 145414-31-9 | Details |
| 2-Amino-5-fluorobenzaldehyde | C7H6FNO | 146829-56-3 | Details |
| (3R,5S,E)-ethyl 7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate (Pitavastatin Impurity） | C27H28FNO4 | 167073-19-0 | Details |
| Iso-FK-506 (iso-Tacrolimus) | C44H69NO12 | 134590-88-8 | Details |
| (R)-N,5-bis(4-fluorophenyl)-2-(4-hydroxybenzyl)pentanamide (Ezetimibe Impurity） | C24H23F2NO2 | 1510820-22-0 | Details |
| Isoleucine Valsartan | C25H31N5O3 | 137862-78-3 | Details |
| Tetraammineplatinum(II)chloride hydrate | Cl2H14N4OPt | 13933-33-0 | Details |
| Dolutegravir Impurity 42 | C20H19F2N3O5 | 1357289-29-2 | Details |
| Moxifloxacin impurity 1 | C21H22FN3O5 | 1395056-41-3 | Details |
| 4'-Methyl-[1,1'-biphenyl]-3-carboxylic acid | C14H12O2 | 147404-69-1 | Details |
| N-Benzoyl-L-phenylalanine 2-naphthalenyl ester | C26H21NO3 | 15873-25-3 | Details |
| 4-(trifluoromethyl)phenyl]thiourea | C8H7F3N2S | 1736-72-7 | Details |
| 4-(2-Ethoxycarbonyl-acetyl)-piperidine-1-carboxylic acid benzyl ester | C18H23NO5 | 167414-75-7 | Details |
| Ceriumoxide | Ce2O3 | 1345-13-7 | Details |
| ethyl 1-cyclopropyl-7,8-difluoro-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate (Moxifloxacin Impurity） | C16H15F2NO4 | 1329836-33-0 | Details |
| 2-Ethyl-2,6,6-trimethylpiperidin-4-one | C10H19NO | 133568-79-3 | Details |
| 6,8-Dibromo-3-cyclohexyl-3-methyl-1,2,3,4-tetrahydroquinazolin-3-ium chloride (Bromhexine Impurity) | C15H21Br2ClN2 | 1660957-93-6 | Details |
| 2-Methyl-3-phenylprop-2-en-1-ol | C10H12O | 1504-55-8 | Details |
| Boc-Asp(OBzl)-OSu | C20H24N2O8 | 13798-75-9 | Details |
| 2-(3,5-Dibromo-2-pyridylazo)-5-(diethylamino)phenol | C15H16Br2N4O | 14337-54-3 | Details |
| 3-Fluoro-4-chlorobenzyl chloride | C7H5Cl2F | 160658-68-4 | Details |
| 1-(3,4-Dimethylphenyl)-N-methylmethanamine | C10H15N | 165741-71-9 | Details |
| Cefditoren Impurity 28 | C25H28N6O7S3 | 138514-32-6 | Details |
| O-(2-(Trimethylsilyl)ethyl)hydroxylamine hydrochloride | C5H16ClNOSi | 153502-27-3 | Details |
| Molybdenum chloride oxide (MoCl2O2), (T-4)- | Cl2MoO2 | 13637-68-8 | Details |
| D-(+)-Galacturonic acid (sodium) | C6H11NaO7 | 14984-39-5 | Details |
| (S)-Methyl 6-amino-2-benzamidohexanoate hydrochloride | C14H21ClN2O3 | 14280-01-4 | Details |
| Osmium(III) chloride | Cl3Os | 13444-93-4 | Details |
| Germanium(II)iodide | GeI2 | 13573-08-5 | Details |
| 1-Phenyl-2-(pyridin-4-yl)ethanone | C13H11NO | 1620-55-9 | Details |
| N-Hydroxy-4-nitrobenzimidamide | C7H7N3O3 | 1613-86-1 | Details |
| 5-(Benzyloxy)pyrimidine-2-carbonitrile | C12H9N3O | 166672-22-6 | Details |
| Diphenyl(Trimethylsilyl)phosphine | C15H19PSi | 17154-34-6 | Details |
| 7-Fluoro-1,2,3,4-tetrahydronaphthalen-2-amine | C10H12FN | 173998-63-5 | Details |
| 4-(4-Chlorophenyl)cyclohexanone | C12H13ClO | 14472-80-1 | Details |
| (R)-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)acetamide (Sitagliptin Impurity） | C18H17F6N5O2 | 1379666-94-0 | Details |
| 5-[(Hexahydro-4-hydroxy-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline | C14H17N3O3S | 1350827-92-7 | Details |
| 2,5-Bis(2-ethylhexyl)-3,6-bis(5-(trimethylstannyl)thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione | C36H56N2O2S2Sn2 | 1392422-47-7 | Details |
| Borane 4-methylmorpholine complex | C5H14BNO | 15648-16-5 | Details |
| (1R,2R)-1-amino-2-(difluoromethyl)-N-((1-methylcyclopropyl)sulfonyl)cyclopropane-1-carboxamide hydrochloride | C9H15ClF2N2O3S | 1360828-80-3 | Details |
| Magnesium 3-hydroxybutanoate | C4H10MgO3 | 163452-00-4 | Details |
| 1,2,5-Pentanetriol | C5H12O3 | 14697-46-2 | Details |
| 2,2-Dioctyl-1,3,2-dioxastannepine-4,7-dione | C20H36O4Sn | 16091-18-2 | Details |
| H-His-Ala-OH | C9H14N4O3 | 16874-75-2 | Details |
| 1,2,3,4-Tetraphenyl-1,3-cyclopentadiene | C29H22 | 15570-45-3 | Details |
| 2-[2,4-bis(2-methylbutan-2-yl)phenoxy]acetic acid | C18H28O3 | 13402-96-5 | Details |
| 4-Amino-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one | C8H11N3O3S | 134680-32-3 | Details |
| 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one (Ibrutinib Impurity） | C25H26N6O4 | 1654820-87-7 | Details |
| Rivaroxaban Impurity 29 | C14H17N3O4 | 1411775-06-8 | Details |
| (2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | C21H25ClO6 | 1373321-04-0 | Details |
| But-2-yne-1,4-diyl diacetate | C8H10O4 | 1573-17-7 | Details |
| Cesium tungsten oxide | Cs2O4W | 13587-19-4 | Details |
| O-Isopropyl ethylthiocarbamate | C6H13NOS | 141-98-0 | Details |
| 5-Hydroxypyrimidin-4(3H)-one | C4H4N2O2 | 15837-41-9 | Details |
| 1,1'-Biphenyl]-4-yl acetate | C14H12O2 | 148-86-7 | Details |
| 2-(2-Chloroethoxy)ethyl acetate | C6H11ClO3 | 14258-40-3 | Details |
| (T-4)-[[2,2′,2′′-(Nitrilo-κN)tris[ethanolato-κO]](3-)]boron | C6H12BNO3 | 15277-97-1 | Details |
| 1-Benzylquinolin-1-ium chloride | C16H14ClN | 15619-48-4 | Details |
| 2,2'-(((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(4,1-phenylene))diacetamide (Atenolol Impurity) | C19H22N2O5 | 141650-31-9 | Details |
| Tetraallyloxyethane | C14H22O4 | 16646-44-9 | Details |
| 1-Isopropylpiperazine hydrochloride | C7H17ClN2 | 137186-14-2 | Details |
| Ezetimibe (3S,4S,3'R)-Isomer (Ezetimibe Impurity） | C24H21F2NO3 | 1478664-18-4 | Details |
| Ammonium cobalt(II) sulfate hexahydrate,98.00% | CoH20N2O14S2 | 13586-38-4 | Details |
| Product Total： Product Page： | ||||
| 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 | ||||